Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinoma

This publication has 48 references indexed in Scilit:

• MIB-1 in Endometrial Carcinoma: Prognostic Significance with 5-Year Follow-Up
  Gynecologic Oncology, 1999
• Prognostic Significance of Angiogenesis and Ki-67, p53, and p21 Expression: A Population-Based Endometrial Carcinoma Study
  Journal of Clinical Oncology, 1999
• A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma: Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction
  Cancer, 1996
• Mutant p53 protein as a predictor of survival in endometrial carcinoma
  European Journal of Cancer, 1996
• Expression of MIB-1 (Paraffin ki-67) and AgNOR Morphology in Endometrial Adenocarcinomas of Endometrioid Type
  International Journal of Gynecological Pathology, 1994
• Letters to the editor
  The Journal of Pathology, 1992
• Comparison between flow cytometry and image cytometry in ploidy distribution assessments in gynecologic cancer
  Cytometry, 1992
• The prognostic significance of DNA measurements in endometrial carcinoma
  Cytometry, 1984
• Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
  International Journal of Cancer, 1983
• Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA Replication
  Science, 1982